Artificial intelligence (AI) poses unlimited opportunity for us to make a transformative impact on patients. Whether it be through new drug combinations, improved medical diagnostics, better accuracy in personalized medicine, or many other benefits – AI could save scientists valuable research time and bring new treatments to patients more quickly.
For this reason, Johnson & Johnson Innovation and Janssen Research & Development launched the Artificial Intelligence for Drug Discovery QuickFire Challenge. Johnson & Johnson Innovation will award up to $100,000 in grants, one year of JLABS residency & mentorship to the individuals or teams who submit the best ideas, technologies, or solutions that are using artificial intelligence to advance healthcare.
On December 12th, visit at JLABS @ Toronto to hear from the finalists of this challenge and choose the winner(s) with the help of a judging panel & the attendees.
During deliberations attendees will hear from an esteemed panel of experts in the artificial intelligence/machine learning field, with speakers from Janssen R&D, Real Ventures, Vector Institute, University of Toronto & Cyclica Inc.